Cargando…

Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

Patients with COVID-19 are increasingly reported to suffer from a wide range of neurological complications, affecting both the central and peripheral nervous system. Among central manifestations, cognitive and behavioral symptoms are to date not exhaustively detailed. Furthermore, it is not clear wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stracciari, Andrea, Bottini, Gabriella, Guarino, Maria, Magni, Eugenio, Pantoni, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040761/ https://www.ncbi.nlm.nih.gov/pubmed/33846880 http://dx.doi.org/10.1007/s10072-021-05231-0

Ejemplares similares

Comparison of Oxford Cognitive Screen and Montreal Cognitive Assessment feasibility in the stroke unit setting. A pilot study
por: Brambilla, Michela, et al.
Publicado: (2021)

When the Past is Lost: Focal Retrograde Amnesia. Focus on the“Functional” Form
por: Stracciari, Andrea, et al.
Publicado: (2008)

The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia
por: Manini, Arianna, et al.
Publicado: (2021)

Late Onset Bipolar Disorder due to a Lacunar State
por: Antelmi, Elena, et al.
Publicado: (2014)

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
por: Yu, Hai-qiong, et al.
Publicado: (2020)

Teleneuropsychology for vascular cognitive impairment: Which tools do we have?
por: Salvadori, Emilia, et al.
Publicado: (2023)

Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
por: Neidleman, Jason, et al.
Publicado: (2021)

Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
por: Neidleman, Jason, et al.
Publicado: (2021)

Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment
por: Pantoni, Leonardo, et al.
Publicado: (2019)

Skin Manifestation of SARS-CoV-2: The Italian Experience
por: Cazzato, Gerardo, et al.
Publicado: (2021)

Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
por: Pensato, Umberto, et al.
Publicado: (2021)

Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets
por: Salvadori, Emilia, et al.
Publicado: (2022)

Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19
por: Sberna, Giuseppe, et al.
Publicado: (2021)

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.
por: Ma, Lina, et al.
Publicado: (2021)

Elucidating the distinct structural features of the SARS-CoV-2 spike protein fusion domain
por: Birtles, Daniel
Publicado: (2022)

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
por: Ma, Lina, et al.
Publicado: (2021)

High-specificity targets in SARS-CoV-2 N protein for serological detection and distinction from SARS-CoV
por: Yu, Jianhai, et al.
Publicado: (2022)

Rapidly progressive dementia and intractable diarrhea: a teaching case report and a systematic review of cognitive impairment in Whipple’s disease
por: Manini, Arianna, et al.
Publicado: (2022)

Neurotropism of SARS-CoV 2: Mechanisms and manifestations
por: Conde Cardona, Giancarlos, et al.
Publicado: (2020)

Update on Neurological Manifestations of SARS-CoV-2
por: Valiuddin, Hisham M., et al.
Publicado: (2020)

Gastrointestinal manifestations and SARS-CoV-2 infection
por: Pizuorno, Antonio, et al.
Publicado: (2021)

Investigating Neurological Manifestations of SARS-CoV-2
por: Mozafar, Maryam, et al.
Publicado: (2021)

Cutaneous Manifestations of SARS-CoV-2 Infection
por: Huynh, Thy, et al.
Publicado: (2022)

Neuropsychiatric manifestations of SARS-CoV-2 infection
por: Nogueira, V., et al.
Publicado: (2021)

Oral manifestations in SARS-CoV-2 infection
por: Tuter, Gulay, et al.
Publicado: (2022)

Review of Neurological Manifestations of SARS-CoV-2
por: ., Priyal, et al.
Publicado: (2023)

Cognitive and affective disorders in critical SARS-CoV-2 patients and caregivers
por: Sambati, Luisa, et al.
Publicado: (2021)

Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences
por: Zóka, András, et al.
Publicado: (2020)

Central nervous system manifestations of monogenic autoinflammatory disorders and the neurotropic features of SARS-CoV-2: Drawing the parallels
por: Renson, Thomas, et al.
Publicado: (2022)

Fractal dimension of the cortical gray matter outweighs other brain MRI features as a predictor of transition to dementia in patients with mild cognitive impairment and leukoaraiosis
por: Marzi, Chiara, et al.
Publicado: (2023)

Nonequilibrium fluctuations as a distinctive feature of weak localization
por: Barone, C., et al.
Publicado: (2015)

Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement
por: Rusina, Robert, et al.
Publicado: (2021)

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
por: Rowntree, Louise C, et al.
Publicado: (2021)

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
por: Butler, Savannah E., et al.
Publicado: (2021)

The Association between Dysnatraemia during Hospitalisation and Post-COVID-19 Mental Fatigue
por: Salvato, Gerardo, et al.
Publicado: (2023)

Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?
por: Patrì, Angela, et al.
Publicado: (2020)

Ocular manifestations of SARS-CoV-2: Literature review()
por: Pérez-Bartolomé, F., et al.
Publicado: (2021)

Manifestations of SARS-COV-2 in patients with chronic liver disease
por: Jiménez-Partida, AE, et al.
Publicado: (2022)

Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions
por: Vastarella, Maria, et al.
Publicado: (2021)

Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo
por: Yeh, Chia-Tsui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69mj445ijmqb5mj2jp01e6ck3j